Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul 11:9:916588.
doi: 10.3389/fcvm.2022.916588. eCollection 2022.

Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom

Priyansh Faldu  1 , Kamal Sharma  2 , Shaival Sharma  1 , Smeet Ramani  1 , Nain Dadhania  1 , Ashwati Konat  3
Affiliations
Comment

Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom

Priyansh Faldu et al. Front Cardiovasc Med. .
No abstract available

Keywords: HeartMate II; HeartWare (HVAD); cost-effectiveness; destination therapy (DT); heart failure; left ventricular assist device (LVAD).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

References

    1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. . Long-term use of a left ventricular assist device for end-stage heart failure. New Engl J Med. (2001) 345:1435–43. 10.1056/NEJMoa012175 - DOI - PubMed
    1. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. . Advanced heart failure treated with continuous-flow left ventricular assist device. New Engl J Med. (2009) 361:2241–51. 10.1056/NEJMoa0909938 - DOI - PubMed
    1. Neyt M, Leroy R, Devos C, Van Brabandt H. Left ventricular assist devices in the treatment of end-stage heart failure. KCE. (2016) 16:264. - PubMed
    1. Neyt M, Van den Bruel A, Smit Y, De Jonge N, Erasmus M, Van Dijk D, et al. . Cost-effectiveness of continuous-flow left ventricular assist devices. Int J Technol Assess Health Care. (2013) 29:254–60. 10.1017/S0266462313000238 - DOI - PubMed
    1. Pulikottil-Jacob R, Suri G, Connock M, Kandala NB, Sutcliffe P, Maheswaran H, et al. . Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure. J Heart Lung Transplant. (2014) 33:350–8. 10.1016/j.healun.2014.01.003 - DOI - PubMed

LinkOut - more resources